Aqueous Humor and Plasma Levels of Vascular Endothelial Growth Factor and Nitric Oxide in Patients with Pseudoexfoliation Syndrome and Pseudoexfoliation.

Slides:



Advertisements
Similar presentations
Biomechanical Properties of the Cornea in Normal- Tension Glaucoma Authors: Leonidas Traipe Ines Cayuqueo Fabiola Cerfogli Claudia Goya Allister Gibbons.
Advertisements

CATARACT SUEGRY AND DIABETES Indications of surgery: 1) Visual loss 2)Surveillance of retinopathy 3)Laser therapy.
Use of a Novel Y- Suture Technique to Reduce Detachments in Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK) Habeeb Ahmad, MD Martin Heur,
Incidence of Blepharitis in Patients Undergoing Phacoemulsification Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD The authors of this poster have.
Early Outcomes of Descemet’s Stripping Automated Endothelial Keratoplasty in Pseudophakic Eyes with Anterior Chamber Intraocular Lenses Preeya K. Gupta.
Astigmatism Following 2 IOL Injection Techniques: Wound Assisted Versus Wound Directed Jay J. Meyer, MD Hart B. Moss, MD Kenneth L. Cohen, MD University.
Anupama Kotha 1, Simar J. Singh 1, William B. Trattler 1,2, Carlos Buznego 1,2 The authors have no financial interest in the subject matter of this poster.
Anterior Chamber Depth, Iridocorneal Angle Width, and Intraocular Pressure Changes After Phacoemulsification: Narrow vs Open Iridocorneal Angles Huang.
Phaco-drainage Phacosection Amporn technique
Phacoemulsification with Goniosynechialysis in the Management of Refractory Acute Angle-closure Glaucoma Ghasem Fakhraie*, MD, Mahmoud Jabbarvand, MD,
The Effect of the Restor Multifocal IOL on Frequency Doubling Perimetry Elizabeth Yeu, MD1, Elizabeth Woznak, BS2, Nicole Kesten, BS2, Steven VL Brown,
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Intraocular Pressure Risk Factors Parekh A, Srivastava S, Bena J, Albini T, Nguyen.
Transparency of Transition from 2.75 mm to 1.8 mm Microincision Surgery Jay McDonald II, MD Adjunct Clinical Professor University of Arkansas School of.
Somasheila I. Murthy, Prashant Garg, Pravin K. Vaddavalli
Will my Glaucoma patient lose vision ?
Effects of IOP Lowering Agents on Myopic Regression after Refractive Surgery Lim, Taehyung M.D., Hong, So Jin M.D., Cho, Beom Jin M.D., Ph.D. Chung Kyu-Hyung.
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Trabeculectomy for Open-Angle Glaucoma Takihara Y, Inatani M, Ogata-Iwao M, et.
Effects of Smoking on Corneal Thickness Candice Giordano, MD February 25, 2011.
TARIQ ALASBALI WHICH PATIENTS ARE AT RISK FOR THE PROGRESSION?
Neeti Parikh, MD Fuxiang Zhang, MD Department of Ophthalmology Henry Ford Hospital A Comparison Of Patient Satisfaction With Modified Monovision Versus.
Purpose: Introduction:  At initial evaluation: For post-op day # 0 patients: Pre-op VA was 20/50.6 (0.395 ± 0.198); Post-op VA was 20/102.0 (0.196 ± 0.162);
*Financial Interest: The authors have no financial interest in the subject matter of this poster. *Disclosure of Unapproved/Off-Label Use: The use of cholesterol.
Management of Aniridic Keratopathy with Allograft Limbal Stem Cell Transplantation Followed by Phacoemulsification Surgery Sibel Aksoy, MD, Yonca A. Akova,
Glaucoma and Penetrating Keratoplasty : Incidence, Risk Factors, and Outcomes Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice Hugo Y. Hsu and Sean L. Edelstein The authors have no financial interest.
Cataract Surgery After Trabeculectomy: The Effect on Trabeculectomy Function Husain R, Liang S, Foster PJ. Cataract surgery after trabeculectomy: the effect.
Riley Hall BSc α, Robert Mitchell MD, FRCSC β University of Saskatchewan α, University of Calgary β Authors have no financial interest Comparison of postoperative.
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: VEGFA and VEGFR1 and Response to Anti-VEGF Hagstrom SA, Ying G, Pauer GJT, et.
Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting.
Combined Phacoemulsification and Ahmed Glaucoma Drainage Implant Surgery Leonidas Traipe, M.D. Felipe Valenzuela, M.D. Carlos Nieme, M.D Juan Stoppel,
Inhibition of Experimental Corneal Neovascularization by Bevacizumab (Avastin) Baskent University, School of Medicine Department of Ophthalmology, Ankara.
Endothelial Keratoplasty in Patients With an Anterior Chamber Intraocular Lens: A Montreal Experience Georges M. Durr, MD 1,2 Johanna Choremis, MD, FRCSC.
Clinical outcome of DALK in Keratoconus – A one year follow up
EFFECT OF RESVERATROL AND BEVACIZUMAB ON EXPERIMENTAL CORNEAL NEOVASCULARIZATION Selim Doganay, MD¹; Penpe Gul Firat, MD¹; Cem Cankaya, MD¹; Hale Kirimlioglu,
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: AMD in the Age-Related Eye Disease Study Chew EY, Clemons TE, Agrón E, et al;
PHACO-TRAB VERSUS PHACO ONLY IN EYES WITH ADVANCED OR END-STAGE GLAUCOMA WITH CONTROLLED INTRAOCULAR PRESSURE AND VISUALLY SIGNIFICANT CATARACT Liaska.
Urrets-Zavalia Syndrome After Lamellar Corneal Transplant: Two Case Reports Timothy Y. Chou, MD, Sujata P. Prabhu, MD, Justin Dexter, MD Department of.
Adriana S. Forseto1, MD Walton Nosé1,2, MD
Dr. Abdullah Al-Amri Ophthalmology Consultant
Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Glaucoma in the Adult Eye.
Nang-Hee Song(MD) 1, Jae-Woong Koh (MD/PhD) 1, Gil-Joong Yoon (MD/PhD) 2 Department of Ophthalmology, Chosun University College of Medicine, Gwangju, Republic.
The effect of corneal edema on intraocular pressure measurements after phacoemulsification surgery Ilker Eser M.D. 1 Arzu Taskiran-Comez M.D. 1 Baris Komur.
Zonular Weakness in Patients with Primary Angle-Closure Glaucoma Yong Yeon Kim 1, Keny Kirti 2, Bokun Rho 1 Department of Ophthalmology, Korea University.
Two Cases of Subconjunctival Bevacizumab Injection to Prevent Bleb Failure after Trabeculectomy Dongwook Lee, Min Ahn, In-Cheon You, Daegyu Lee Chonbuk.
Diminished Endothelial Cell Counts in Corneas with Krukenberg Spindles Authors: Tod M. Haller1, Chad B. Haller2, Melvin L. Haller1, Judah Beck3, Keith.
Corneal vs. Scleral Incisions: Managing Lens luxation in homocystinuria Suqin Guo, MD,* Tatyana Milman, MD, N Bhagat, MD, D Chu, MD and R Fechtner, MD.
Yonca Aydin Akova MD, Leyla Erkanli Asena MD
Endoscopic Management of Displaced IOL Causing Recurrent Hyphema in Patient With Pseudoexfoliation J. M. Rouse, M. A. Khaimi Dean McGee Eye Institute,
Liquifaction Method and Extent of Posterior Capsule Opacification: Two-Year Follow-up Marie Kalfertova, Mariya Burova, Pavel Rozsival, Nada Jiraskova Nada.
Assessment of Anterior Segment Measurements with Swept Source Anterior Segment OCT Before and After Trabectome Surgery Handan Akil, Mayss Al-Sheikh, SriniVas.
D.r Nishant Nawani, MS Dr. Surinder Singh Pandav, MD Dr. Amit Gupta, MD Dr. Sushmita Kaushik, MD Advanced Eye Centre PGIMER, Chandigarh The authors have.
(Relates to Chapter 22, “Nursing Management: Visual and Auditory Problems,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier.
1. Ankara University School of Medicine, Department of Ophthalmology
Pseudoexfoliation syndrom and cataract: results and complication frequency in immature and mature cataract surgery Marijana Bilen Babić Department of.
IOP control and corneal endothelial cell density changes
LONG-TERM RESULTS OF DEEP SCLERECTOMY IN NORMAL-TENSION GLAUCOMA
Comparison of Endothelial Cell Loss After Phacoemulsification Performed by Third Year Residents and Anterior Segment Surgeons Alexandra Braunstein, MD.
INTRODUCTION TO GLAUCOMA
Early Intraocular Pressure Rise After Phacoemulsification In Non-Glaucomatous And Eyes With Primary Open-Angle Glaucoma Milos Todorovic 1, Suncica Sreckovic.
Authors have no any financial interest in the subject matter
Blood Reflux In Schlemm’s Canal Of Normal Cataract Patients: Simple Way To Identify The Trabecular Meshwork With Healthy Collector Channel Masahiro Maeda1,
Bevacizumab and corneal patology
Effects of the “Pop & Prechop” Supracapsular Phacoemulsification Technique on Endothelial Cell Counts and Corneal Clarity Brandon Rodriguez, MD Michael.
Associate Professor of Ophthalmology
Sirel G. Güngör, MD Cem Küçükerdönmez, MD Yonca A. Akova, MD
versus 2.75mm Incision Phacoemulsification
Early Experience With Anterior Chamber Phakic IOL
Winthrop University Hospital
The Effect of Corneal Thickness on Ocular Drug Penetration
Presentation transcript:

Aqueous Humor and Plasma Levels of Vascular Endothelial Growth Factor and Nitric Oxide in Patients with Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma Yonca A. Akova, MD, Mehmet Borazan, MD; Aylin Karalezli, MD; Cem Kucukerdonmez, MD; Ahmet Akman, MD; Sevsen Kulaksizoglu, MD Baskent University, School of Medicine Department of Ophthalmology, Ankara, Turkey

Financial Interest  I have received research reimbursement from Alcon and Allergan which was not relevant to the subject matter of this poster  None of the authors have financial interest in the subject matter of this poster

Introduction  Pseudoexfoliation syndrome (PXS): Common Age-related May lead to pseudoexfoliative glaucoma (PXG) Specific pathogenetic mechanism and its progression to PXG remain, poorly understood  Pseudoexfoliation fibrils: Multifocal Produced by various intraocular cell types

Purpose To investigate the levels of vascular endothelial growth factor (VEGF) and nitric oxide (NO) in aqueous humor and plasma in eyes with pseudoexfoliation syndrome (PXS), pseudoexfoliative glaucoma (PXG), and normal controls

Patients and Methods  Prospective, randomized clinical study  37 patients with PXS  15 patients with PXG  32 control subjects  VEGF levels: Measured with enzyme-linked immunosorbent assay  NO levels: Measured with chemiluminescence method (nitrate/nitrite colorimetric assay kit)

Patients and Methods  Pseudoexfoliation syndrome: Presence of typical pseudoexfoliation material on the anterior lens capsule in one or both eyes A normal optic disk appearance and visual field testing (Humphrey 30-2 SITA standard test) IOP < 21 mm Hg  Pseudoexfoliative glaucoma: IOP > 21 mm Hg Typical glaucomatous cupping and visual field loss in one or both eyes Pseudoexfoliative material on the anterior lens capsule  Control group: Age-and sex-matched patients with cataracts Absence of any pseudoexfoliation material at the anterior segment of the eye

Patients and Methods  Aqueous humor samples: (0.1mL) Collected at the beginning of, phacoemulsification surgery through a clear corneal paracentesis Aspirated from the central pupillary area using a 27- gauge needle on a tuberculin syringe Cooled at – 70  C until analyses  Venous blood samples : (5 mL) Collected in the fasting state just before patients were prepared for cataract surgery Stored in chilled tubes containing EDTA (1mg/mL blood) and heparin (100 IU/mL blood) Centrifuged to obtain plasma Cooled – 70  C until analysis

Results Pseudoexfoliation Syndrome (n=37) Pseudoexfoliation Glaucoma (n= 15) Controls (n=32) P value Age (years) Range Mean±SD72.3 ± ± ± Sex Male, n(%)20 (54)8 (53)17 (53) Female, n(%)17 (46)7 (47)15 (47)0.82

Pseudoexfoliation Syndrome (n=37) Pseudoexfoliation Glaucoma (n= 15) Controls (n=32) Aqueous humor VEGF (µmol/mL) ± 55.47* ± 46.65* ± NO (ng/mL)34.96 ± $ ± # ± Plasma VEGF (µmol/mL)72.82 ± 23.82*83.70 ± 16.35*44.08 ± NO (ng/mL)18.89 ± ± ± 5.60 Results VEGF: vascular endothelial growth factor; NO: nitric oxide *: P <.001, PXS vs control, PXG vs control # : P =.001, PXG vs control $ : P <.05, PXS vs control

Discussion  Well documented iris vasculopathy, with manifestations of blood aqueous barrier defects, vessel dropout, microneovascularization, hypoperfusion, and anterior chamber hypoxia in PSX 1  Aqueous humor VEGF levels were found higher in neovascular glaucoma, POAG, angle-closure glaucoma and PXG 2,3  Controversial findings about aqueous NO levels in glaucoma in the literature 4-6  Kotikoski et al (only report on the aqueous concentration of NO in eyes with PXG) showed lower NO levels in 6 patients with PXG and 2 patients with PXS compared with controls 7 1. Helbig H, et al. Ger J Ophthalmol 1994;3: Tripathi RC,et al. Ophthalmology 1998;105: Hu DN, et al. J Glaucoma 2002;11: Chang CJ, et al. 2000;16: Galassi F, et al. J Ophthalmol 2004;88: Kosior-Jarecka E, et al. Klin Oczna 2004;106: Kotikoski H, et al. Acta Ophthalmol Scand 2002;80:

Conclusions  Aqueous humor VEGF and NO levels and plasma VEGF levels in patients with PXS and PXG were found higher than in controls  No significant difference was found in plasma NO concentrations compared with controls  The aqueous humor and plasma VEGF and NO levels were not significantly different in eyes with PXS compared with PXG  Improved understanding of the role of VEGF and NO in the pathogenesis of PXS and related glaucoma may change anti- glaucomatous treatment and anti-VEGF drugs may be an option for these patients

NAME: Yonca Aydın Akova, M.D. TITLE: Professor in Ophthalmology DATE AND PLACE OF BIRTH: October 21, 1960, Turkey 1983: Doctor of Medicine, Istanbul University, School of Medicine 1990: Istanbul University, School of Medicine, Department of Ophthalmology 2000:Professor of Ophthalmology, Baskent University, School of Medicine, Department of Ophthalmology, Ankara, Turkey 2002: Chairperson, Baskent University, School of Medicine, Department of Ophthalmology, Ankara, Turkey NAME: Mehmet Borazan, M.D. TITLE: Fellow in Ophthalmology DATE AND PLACE OF BIRTH: August 10, 1974, Turkey 1998: Doctor of Medicine, Inonu University, School of Medicine 2005 : Başkent University, School of Medicine, Department of Ophthalmology NAME: Aylin Karalezli, M.D. TITLE: Fellow in Ophthalmology DATE AND PLACE OF BIRTH: July 4, 1974, Turkey 1998: Doctor of Medicine, Ankara University, School of Medicine 2005 : Başkent University, School of Medicine, Department of Ophthalmology NAME: Cem Küçükerdönmez, M.D. TITLE: Fellow in Ophthalmology DATE AND PLACE OF BIRTH: October 9, 1975, Turkey 1999: Doctor of Medicine, Hacettepe University, School of Medicine 2003 : Başkent University, School of Medicine, Department of Ophthalmology NAME: Sevsen Kulasizoglu, M.D TITLE: Fellow in Biochemistry DATE AND PLACE OF BIRTH: April 10, 1974, Turkey 1998: Doctor of Medicine, Hacettepe University, School of Medicine 2003 : Başkent University, School of Medicine, Department of Bıochemistry NAME: Ahmet Akman, M.D. TITLE: Professor in Ophthalmology DATE AND PLACE OF BIRTH: March 20, 1968, Turkey 1991: Doctor of Medicine, Hacettepe University, School of Medicine 1995: Hacettepe University, School of Medicine, Department of Ophthalmology 2007:Professor of Ophthalmology, Baskent University, School of Medicine, Department of Ophthalmology, Ankara, Turkey